TipRanks
Tue, April 7, 2026 astatine 9:45 AM CDT 1 min read
Stifel expert Alex Thompson notes that Amgen (AMGN) announced affirmative topline results for the Phase 3 on-body infusion survey of Tepezza achieving a 77% complaint of proptosis response, which comes successful higher connected some an implicit and placebo-adjusted ground compared to Viridian Therapeutics’ (VRDN) elegrobar. However, with elegrobart’s subcutaneous injection illustration versus on-body infusion, the steadfast sees a way towards differentiation successful the market, says the analyst, who has a Buy standing connected Viridian shares.
-
Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
-
Discover top-performing banal ideas and upgrade to a portfolio of marketplace leaders with Smart Investor Picks
Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>
See today’s best-performing stocks connected TipRanks >>
Read More connected VRDN:
Disclaimer & DisclosureReport an Issue
-
Evercore cuts Viridian terms target, removes from ‘Tactical Outperform’ list
-
Viridian Therapeutics terms people lowered to $37 from $44 astatine Wedbush
-
Viridian Therapeutics terms people lowered to $20 from $29 astatine Wells Fargo
-
Viridian Therapeutics terms people lowered to $36 from $41 astatine Goldman Sachs
-
Viridian Therapeutics terms people lowered to $22 from $34 astatine H.C. Wainwright

1 hour ago
2





English (CA) ·
English (US) ·
Spanish (MX) ·